Nicodicosapent
Nicodicosapent is a fatty acid niacin conjugate that is also an inhibitor of the sterol regulatory element binding protein (SREBP), a key regulator of cholesterol metabolism proteins such as PCSK9, HMG-CoA reductase, ATP citrate lyase, and NPC1L1.
Product Specifications
CAS Number
1269181-69-2
UNSPSC
12352005
Target
Autophagy; Fatty Acid Synthase (FASN)
Type
Reference compound
Related Pathways
Autophagy; Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/Nicodicosapent.html
Purity
99.79
Solubility
DMSO : 100 mg/mL (ultrasonic) |Ethanol : 3.33 mg/mL (ultrasonic)
Smiles
O=C(C1=CC=CN=C1)NCCNC(CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)=O
Molecular Formula
C28H39N3O2
Molecular Weight
449.63
References & Citations
[1]Vu CB, et al. Synthesis and Characterization of Fatty Acid Conjugates of Niacin and Salicylic Acid. J Med Chem. 2016 Feb 11;59 (3) :1217-31.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Human IgM Immunoglobulin (DA4-4), CF405S conjugate, 0.1mg/mL
gamma Adaptin (AP1G1) (NM_001030007) Human Over-expression Lysate
